Purchase Order 75N93019P00634
Award Date 6/5/19
Potential Completion Date 6/12/19
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Monmouth Junction, South Brunswick Township, NJ 08852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $28,000 firm fixed price purchase order to Karebay Biochem Inc. under request for quotes RFQ-NIAID-23-2175814. The contract calls for the delivery of a peptide library consisting of 408 peptides, each with 1 milligram of a 15 amino acid peptide at 95% purity. The place of performance is China. The award was set aside for total small business and will...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $19,800 firm fixed price purchase order to Karebay Biochem Inc., a for-profit small business, to synthesize 200 grams of compound NCGC00413972. This order supports NIH's biomedical research programs, particularly in the areas of drug discovery and infectious disease. Karebay Biochem has received multiple prior purchase orders from NIH entities to...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Bachem Americas, Inc. for the custom synthesis of 20 mg peptides with >95% purity, including quality control analytical services. The contract ceiling value is $4,315.00 and the ultimate completion date is March 26, 2016. Bachem Americas, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical ingredients...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A & A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A & A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...
- This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to JPT Peptide Technologies GmbH, a foreign-owned for-profit manufacturer of custom peptides and related products. The contract, valued at $5,497.50, is for the delivery of 40 aliquots of a Marburg glycoprotein-Musoke peptide mixture. The contract supports research related to infectious diseases and does not have a set-aside...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to A & A Labs LLC, doing business as Synthetic Biomolecules. The $8,482.00 contract is for the custom synthesis of 15-mer peptides. The contract is set aside for small businesses and the awardee is a minority-owned, self-certified small disadvantaged business. The place of performance is San Diego,...
- This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,610 firm fixed price purchase order to JPT Peptide Technologies GmbH of Germany. The contract is to provide 20 units of a 158-peptide mixture and 25 units of a 102-peptide mixture related to the SARS-CoV-2 spike glycoprotein and nucleocapsid phosphoprotein, respectively, as referenced in the original solicitation. The peptides will support ongoing NIAID...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and related research products. The $3,620 firm fixed price purchase order is for the delivery of peptide microarrays displaying peptides from a previous order, in support of NIAID's research activities. The award has no set-aside...
- This firm fixed price purchase order for $17,272 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to JPT Peptide Technologies GMBH of Almanya to fulfill a requirement originally solicited under Request for Quotes RFQ-NIAID-2079401. The solicitation sought 18 each of PepMix SARS-CoV-2 (Spike Glycoprotein), consisting of a mixture of 158+157 peptides for use in assay kits. JPT will deliver the requested...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Karebay Biochem Inc., a for-profit small business organization, to provide peptides in support of biomedical research. The $10,435.00 contract does not have a set-aside designation. Karebay Biochem provides chemical and biological research services, including synthesizing chemical compounds, peptides, and other materials, to support NIH projects in areas such as drug discovery and infectious disease research. The company has received multiple previous purchase orders from NIH entities for these types of research services.
Generated 6/1/24, 12:03 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 6/5/19 |